Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005;32(2):178-84.

Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management

Affiliations
Review

Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management

Walid Hassan et al. Tex Heart Inst J. 2005.

Abstract

Amyloidosis comprises a unique group of diseases that share in common the extracellular deposition of insoluble fibrillar proteins in organs and tissues. Cardiovascular amyloidosis can be primary, a part of systemic amyloidosis, or a result of chronic systemic diseases elsewhere in the body. The most common presentations are congestive heart failure-mainly a restrictive infiltrative pattern--and conduction system disturbances. Recent developments in imaging techniques and extracardiac tissue sampling have minimized the need for invasive endomyocardial biopsy for amyloidosis. Despite advances in treatment, the prognosis for patients with amyloidosis is still poor and depends on the underlying disease type. Herein, we present new insights and recent advances in cardiovascular amyloidosis.

PubMed Disclaimer

Figures

None
Fig. 1 Photomicrograph of a gastric biopsy specimen of a patient with primary amyloidosis shows plasma cells with expression of kappa light chain (Immunoperoxidase, orig. ×400).
None
Fig. 2 Photomicrograph of a gastric biopsy specimen of a patient with primary amyloidosis shows plasma cells lacking expression of lambda light chain (Immunoperoxidase, orig. ×400).
None
Fig. 3 Doppler echocardiographic study of a patient in an early stage of cardiac amyloidosis reveals an impaired relaxation pattern with reversal of E/A ratio.
None
Fig. 4 Doppler echocardiographic study of a patient in a late stage of cardiac amyloidosis reveals a severe restrictive pattern.
None
Fig. 5 Electrocardiogram of a patient with cardiac amyloidosis shows a diffuse low-voltage QRS complex.
None
Fig. 6 Echocardiogram of a patient with immunoglobulin (AL) amyloidosis shows thickened ventricular and atrial walls, abnormal myocardial texture, atrial dilatation, and pericardial effusion. LA = left atrium; LV = left ventricle; RA = right atrium; RV = right ventricle
None
Fig. 7 Photomicrograph of an endomyocardial biopsy specimen in a patient with immunoglobulin amyloidosis exhibits interstitial eosinophilic amyloid deposits (arrow) (H & E, orig. ×400).
None
Fig. 8 Photomicrograph of endomyocardial biopsy specimen in a patient with immunoglobulin amyloidosis exhibits the metachromatic appearance of amyloid (AL) (Congo red stain, orig. ×400).
None
Fig. 9 Electron micrograph of primary amyloidosis shows the characteristic amyloid fibrils (AL) (Lead citrate, orig. ×1500).

References

    1. Kyle RA. Amyloidosis: a convoluted story. Br J Haematol 2001;114:529–38. - PubMed
    1. Smith RR, Hutchins GM, Moore GW, Humphrey RL. Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloid. Am J Med 1979;66:96–104. - PubMed
    1. Sipe JD, Cohen AS. Review: history of the amyloid fibril. J Struct Biol 2000;130:88–98. - PubMed
    1. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337:898–909. - PubMed
    1. Benson MD. Amyloidosis. In: Scriver CR, editor. The metabolic and molecular bases of inherited disease. Vol 1. 8th ed. New York: McGraw-Hill; 2001. p. 5345–8.